Aprea Therapeutics, Inc.

APRE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$22,850$21,607$28,787$53,076
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$726$914$1,367$3,508
Total Curr. Assets$23,576$22,521$30,154$56,584
Property Plant & Equip (Net)$82$88$2$210
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$40$41$0$0
Tax Assets$0$0$0$0
Other NC Assets$282$0$0$29
Total NC Assets$403$129$2$239
Other Assets$0$0$0$0
Total Assets$23,979$22,650$30,156$56,823
Liabilities
Payables$1,352$1,670$843$1,773
Short-Term Debt$0$0$0$190
Tax Payable$0$0$0$0
Deferred Revenue$0$529$0$0
Other Curr. Liab.$2,009$2,186$2,358$5,353
Total Curr. Liab.$3,361$4,386$3,201$7,316
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,311$1,311$1,311$0
Total NC Liab.$1,311$1,311$1,311$0
Other Liabilities$0-$1,311$0$0
Cap. Leases$0$0$0$190
Total Liabilities$4,672$4,386$4,512$7,316
Equity
Pref Stock$0$1,311$0$0
Common Stock$5$4$3$1
Retained Earnings-$321,042-$308,083-$293,796-$181,134
AOCI-$10,627-$10,611-$10,623-$10,359
Other Equity$350,971$335,644$330,061$240,999
Total Equity$19,307$18,265$25,644$49,507
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$23,979$22,650$30,156$56,823
Net Debt-$22,850-$21,607-$28,787-$52,886